Compromised paraspeckle formation as a pathogenic factor in FUSopathies by Shelkovnikova, Tatyana et al.
Compromised paraspeckle formation
as a pathogenic factor in FUSopathies
Tatyana A. Shelkovnikova1,2,∗, Hannah K. Robinson1, Claire Troakes3,
Natalia Ninkina1,2 and Vladimir L. Buchman1,2,∗
1School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK, 2Institute of Physiologically Active
Compounds Russian Academy of Sciences, 1 Severniy proezd, Chernogolovka 142432, Moscow Region, Russian
Federation and 3Department of Clinical Neuroscience and MRC London Neurodegenerative Diseases Brain Bank,
Institute of Psychiatry, King’s College London, De Crespigny Park, London SE5 8AF, UK
Received October 30, 2013; Revised December 5, 2013; Accepted December 6, 2013
Paraspecklesarenuclear bodies formedbyasetof specializedproteinsassembledon the longnon-codingRNA
NEAT1; they have a role in nuclear retention of hyperedited transcripts and are associatedwith response to cel-
lular stress. Fused in sarcoma (FUS) protein, linked to a number of neurodegenerative disorders, is an essential
paraspeckle component. We have shown that its recruitment to these nuclear structures is mediated by the
N-terminal region and requires prion-like activity. FUS interacts with p54nrb/NONO, a major constituent of
paraspeckles, in an RNA-dependent manner and responds in the same way as other paraspeckle proteins to
alterations in cellular homeostasis such as changes in transcription rates or levels of protein methylation.
FUS also regulates NEAT1 levels and paraspeckle formation in cultured cells, and FUS deficiency leads to loss
of paraspeckles. Pathological gain-of-function FUSmutations might be expected to affect paraspeckle function
in human diseases because mislocalized amyotrophic lateral sclerosis (ALS)-linked FUS variants sequester
other paraspeckle proteins into aggregates formed in cultured cells and into neuronal inclusions in a transgenic
mouse model of FUSopathy. Furthermore, we detected abundant p54nrb/NONO-positive inclusions in motor
neurons of patients with familial forms of ALS caused by FUSmutations, but not in other ALS cases. Our results
suggest that both loss and gain of FUS function can trigger disruption of paraspeckle assembly, which may
impair protective responses in neurons and thereby contribute to the pathogenesis of FUSopathies.
INTRODUCTION
FUS is an abundant, multifunctional RNA/DNAbinding protein
that contributes to various aspects of cellular RNA metabolism
and executes its main functions in the cell nucleus (reviewed
in 1). Initially identified as a protein involved in carcinogenesis
(2), FUS was recently found to be associated with certain forms
of amyotrophic lateral sclerosis (ALS), frontotemporal lobar de-
generation (FTLD) and several less common neurodegenerative
disorders (3–6) that can be coalesced into a group of FUSopa-
thies. The majority of ALS-linked mutations in FUS disrupts
its nuclear localization signal (NLS) and results in nuclear clear-
ance of FUS with accumulation in the cytoplasm where it forms
characteristic non-amyloid inclusions (reviewed in 3). As a
consequence, both loss of nuclear function(s) and gain of toxic
function(s) in the cytoplasm may compromise various cellular
processes in affected neurons, primarily RNA processing (7–
10), axonal transport (11) andneural transmission (12).Multiple,
though fragmented, experimental evidence exists that a fraction
of FUS is associated with various nuclear structures. Recent
studies have demonstrated a functional association of FUS
with Gemini of Cajal bodies (Gems), sites of SMN protein accu-
mulation in thenucleus, anda lossofGems followingFUSdeple-
tion or expression of a mutant with disturbed NLS (9,10). There
are indications that FUS may be associated with nuclear speck-
les, since it interacts with serine–arginine (SR) proteins and
is involved in splicing (13,14). Recently, FUS presence in
another nuclear body, the paraspeckle, was demonstrated in at
least three different studies (15–17). Paraspeckles are built on
the long non-coding RNA (lncRNA) NEAT1, also known as
MENepsilon/beta, which assembles and spatially organizes
core protein constituents of the paraspeckle—p54nrb/NONO,
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paraspeckle protein 1 (PSP1) andPSF (18–21). Paraspeckles are
believed to participate in nuclear retention of long adenosine-
to-inosine hyperedited RNAs, and in storage and rapid release
of certain RNAs under stress conditions (22,23). Most recently,
FUS was shown to directly bind NEAT1 (16), providing a basis
for physical association of the protein with paraspeckles. Inter-
estingly, FUS shares many similarities with paraspeckle pro-
teins, namely RNA/DNA binding capacity, involvement in
chromosomal translocations leading to malignancies (24,25),
interaction with C-terminal domain of RNA polymerase II
(26,27) and redistribution to the perinucleolar region upon tran-
scription inhibition (15,28). Although paraspeckles are absent in
neurons under basal conditions, their formation at the early
stages of ALS, triggered by increased synthesis of NEAT1,
was recently demonstrated (16), suggesting participation of
paraspeckles in response to neuronal stress or damage.
Here we confirmed that FUS is a core paraspeckle protein es-
sential for the integrity of these nuclear bodies and established
possible links between its role in paraspeckles and the pathogen-
esis of FUSopathies.Wealso obtained evidence that dysfunction
of other paraspeckle componentsmay be a contributory factor in
these diseases.
RESULTS
FUS localizes to paraspeckles via its N-terminus
In the interphase nucleus of all cell lines examined, endogenous
FUS protein forms distinct puncta and foci of various size that
are clearly seen in themilieuof diffusenucleoplasmicdistribution
(see Fig. 1A for SH-SY5Y and COS7 cells), suggesting highly
organized subnuclear compartmentalization of the protein.
green fluorescent protein (GFP)-fused full-length FUS overex-
pressed in these cells closely reproduces the pattern typical for
the endogenous protein (Fig. 1A). Immunofluorescence with a
panel of antibodies against the core proteins of known nuclear
bodies was used to test the physical association of FUS with
these structures in neuroblastoma SH-SY5Y cells. FUS was con-
sistently excluded fromnucleolar regions recognized by ethidium
bromide staining, was not present at detectable levels in coilin-
positive Cajal bodies, SMN-positive Gems or PML-positive
PML bodies (SupplementaryMaterial, Fig. S1A) but wasmoder-
ately enriched in Sm antigen-positive nuclear speckles (Supple-
mentary Material, Fig. S1A) and significantly enriched in
paraspeckles detected using antibodies against PSP1 or p54nrb/
NONO (Fig. 1B). Similar patterns were observed for these anti-
bodies in COS7 and MCF7 cell lines (not shown). Even FUS
with deleted NLS and significant degree of nuclear clearance
was markedly enriched in paraspeckles (Fig. 1D), indicating a
strong affinity of the protein to these nuclear bodies. Another
ALS-associated protein, closely related to FUS, TDP-43, was
also detected in paraspeckles consistent with the previous
reports (15,16), although not all FUS-positive paraspeckles
were positive for TDP-43 (Supplementary Material, Fig. S1B).
FUSwas found in a complexwithNEAT1 lncRNA(16), and it
is feasible that as in the case of major paraspeckle proteins (18–
21), the interactionofFUSwithNEAT1 is important for its local-
ization to paraspeckles. However, we observed that C-terminal
region of FUS involved in RNA recognition and binding was
not sufficient to target the protein to paraspeckles (Fig. 1C and
D, panel CT). Addition of an RNA-recognition motif (RRM)
to this C-terminal fragment (CT-RRM) did not change the
pattern of uniformly diffuse nucleoplasmic localization of the
protein and, consistently, full-length FUS lacking RRM
domain only (DRRM) was still directed to paraspeckles (data
not shown). In contrast, the N-terminal fragment of FUS was
able to localize to paraspeckles on its own (Fig. 1C and D,
panel NT). As this N-terminal fragment bears a potent prion-like
domain (aminoacids 1–214) (29), we assessed whether prion-
like activity is necessary for paraspeckle recruitment.We substi-
tuted the first 359 amino acids of FUS with a well-characterized
prion domain from the yeast protein Sup35 (aminoacids 1–125)
and found that the resulting chimeric proteinwas not only predom-
inantly localized to the nucleus and excluded from nucleolar
regionsbut also colocalizedwith paraspeckles (Fig. 1E), complete-
ly recapitulating the pattern of FUSnuclear compartmentalization.
The N-terminal domain of FUS with its prion-like activity was re-
cently proposed to cooperatewithRNA-bindingmotifs in enabling
theprotein entry intonon-membraneboundRNPstructures suchas
RNA granules (30,31). Our data suggest that the paraspeckle is
another RNA–protein entity requiring a protein to possess prion-
like activity for its recruitment and provide further support to the
role of the prion-like domain in phase transitions of FUS protein
in a living cell. However, we cannot completely exclude the possi-
bility thatdirectbindingofFUStoNEAT1RNAalsocontributes to
its targeting to paraspeckles.
FUS and other paraspeckle proteins are recruited
into the same nucleolar caps
Paraspeckle proteins are known to redistribute to the perinucleo-
lar region and become a part of dark nucleolar caps when tran-
scription is inhibited (15,28); the same behaviour was
previously reported for FUS (25). We found that classical cres-
cent shape caps were formed by FUS only in response to
global transcriptional inhibition by actinomycin D, while
specific inhibition of RNA polymerase II by 5,6-dicholoro-b-
D-ribofuranosylbenzimidazole (DRB) induced the protein
redistribution to the perinucleolar space without formation of
typical caps (Fig. 2A). The N-terminal domains of FUS are
largely responsible for nucleolar cap recruitment of the protein
(Fig. 2B and Supplementary Material, Fig. S2A) and this is
mediated by prion-like activity since Sup35–FUS chimeric
protein also readily redistributes to nucleolar caps (Fig. 2C).
Thus, the prion-like domain defines FUS localization to para-
speckles and nucleolar caps. It is known however, that nucleolar
caps formed by different proteins may only partially overlap
(28). To determine whether FUS is a component of the same
caps as other paraspeckle proteinswe immunostained actinomy-
cin D-treated cells with antibodies against paraspeckle proteins
PSP1 and p54nrb/NONO, and against non-paraspeckle proteins
p80 coilin and RNA helicase p68, which are also found in
nucleolar caps. FUS-positive nucleolar caps were distinct from
those formed by p80 coilin (Fig. 2E) and only partially over-
lapped with p68 (Fig. 2F) to form complex three-dimensional
cap-like structures that were especially evident in COS7 cells
(SupplementaryMaterial, Fig. S2B). In contrast, complete colo-
calization was observed with caps formed by paraspeckle pro-
teins PSP1 and p54nrb/NONO (Fig. 2G and Supplementary
Material, Fig. S2C). A related protein, TDP-43, either
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endogenous or overexpressed, was not observed in nucleolar
caps induced by either actinomycin D (SupplementaryMaterial,
Fig. S2D) or DRB (not shown). However, FUS does not play an
essential role in the recruitment of other paraspeckle proteins to
nucleolar caps since this process was not disturbed in FUS-
depleted cells (Fig. 2G).
FUS interacts with a core paraspeckle protein
p54nrb/NONO in an RNA-dependent manner
To assess whether FUS and other paraspeckle proteins can be
present in the same macromolecular complexes we carried
out co-immunoprecipitation experiments with GFP-tagged
FUS protein expressed in SH-SY5Y cells. GFP–FUS
efficiently pulled down endogenous p54nrb/NONO but this
co-immunoprecipitation was completely abolished when
lysates were pretreated with RNase A, suggesting that inter-
action between the two proteins is RNA-dependent (Fig. 3A).
Consistent with this result, the N-terminal part of FUS lacking
major RNA-binding domains (NT) did not precipitate p54nrb/
NONO. Despite structural and functional similarities between
FUS and TDP-43, the latter was not found in complex with
p54nrb/NONO (Fig. 3B). We have also demonstrated
co-immunoprecipitation of endogenous FUS with endogenous
p54nrb/NONO (Fig. 3C). It should be noted that these experi-
mental approaches reveal not only paraspeckle-associated, but
all in vivo complexes containing FUS and p54nrb/NONO. Al-
though p54nrb/NONO is a major paraspeckle protein it has
other intracellular functions, particularly in transcription (26)
and FUS also has been implicated in this process (27,32),
Figure1.N-terminal domainsof FUSare required for targeting the protein to paraspeckles. (A)Both endogenous andoverexpressedFUSare excluded fromnucleolar
regions (arrows) and enriched inmultiple small puncta (arrowheads) in interphase nuclei of neuroblastomaSH-SY5YorCOS7cells. (B) FUS-containing nuclear dots
overlap with paraspeckles (arrowheads) visualized with an antibody against PSP1 or p54nrb/NONO. (C) Domain organization of human FUS protein and schematic
representation of constructs used in the study. (D) FUS lackingNLS and significantly redistributed to the cytoplasm is still enriched in paraspeckles, as is N-terminal
fragmentofFUS(NT),whileC-terminal fragmentof theprotein (CT) fails to localize toparaspeckles. (E)Prion-likeactivityofFUSN-terminaldomains is required for
paraspeckle recruitment. Schematic map of a chimeric protein with N-terminal part of FUS replaced by the prion domain from a yeast protein Sup35 (aminoacids
1–125). Sup35–FUS localizes predominantly to the nucleus where it is excluded from nucleolar regions (arrows) and found in small puncta that overlap with para-
speckle marker PSP1 (arrowheads). Scale bars, 10 mm.
2300 Human Molecular Genetics, 2014, Vol. 23, No. 9
 at A
cquisitions on O
ctober 7, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
suggesting that certain transcription complexes might include
both proteins. To assess whether interaction of FUS and
p54nrb/NONO was preserved upon inhibition of transcription,
we carried out co-immunoprecipitation of these proteins from
cells treatedwith twomechanistically different inhibitors.A sig-
nificant fraction of GFP-labelled FUS was still associated with
p54nrb/NONO in cells treated with actinomycin D but not
DRB and similarly to untreated cells, this interaction was RNA-
dependent (Fig. 3D).As both FUSand p54nrb/NONOare able to
interact with the C-terminal domain of RNA polymerase II
(26,27), a plausible explanation of these data is that while the
FUS–p54nrb/NONO interaction remains intact when the inter-
calating agent actinomycin D stalls the RNA polymerase
complex and prevents elongation, this interaction becomes
impaired when the assembly of a transcription unit containing
FUS and p54nrb/NONO is blocked by DRB, an inhibitor of
Cdk9 and other kinases that regulate integrity and activity of
transcriptional complexes (33). Taken together, our data
suggest that these proteins are components of the same transcrip-
tional complex(es) and come into contact co-transcriptionally
via interaction with RNAs present in these complexes.
Methylation regulates paraspeckle protein distribution
in the nucleus
In our experiments with MCF7 breast cancer cell line we found
FUS and other paraspeckle proteins localized predominantly in
the perinucleolar region in the vast majority of cells (Fig. 4A), a
pattern strikingly different to distribution of these proteins in the
nucleus of other types of cultured cells. It has been previously
demonstrated that this cell line lacksmethylthioadenosine phos-
phorylase (MTAP) gene which affects the methionine salvage
pathway and therefore leads to decreased levels of protein
methylation (34).Moreover, coilin p80 is localized to the perinu-
cleolar region in a fraction of MCF7 cells and this fraction is
increased following inhibition of protein methyltransferases
(35). We hypothesized that this state of hypomethylation is re-
sponsible for triggering the relocalization of paraspeckle pro-
teins to perinucleolar regions in these cells. To test this we first
performed a rescue experiment in MCF7 cells by ectopically
expressing Flag-tagged MTAP. Indeed, in MTAP-expressing
cells paraspeckles, visualized by anti-p54nrb/NONO staining,
were restored and perinucleolar localization of paraspeckle pro-
teins was no longer detected (Fig. 4B). Furthermore, when neuro-
blastoma SH-SY5Y cells characterized by normal paraspeckle
protein distribution were treated for 24 h with methylthioadeno-
sine (MTA), a global methyltransferase inhibitor, a fraction of
cells displayed relocation of paraspeckle proteins to the perinu-
cleolar region (Fig. 4C, arrows). The same result was obtained
in cells overexpressingGFP-fusion full-length FUS protein (Sup-
plementaryMaterial, Fig. S2E). FollowingMTA treatment, para-
speckleswerepreserved inneuroblastomacellswithconventional
FUS distribution (Fig. 4C, arrowheads), but not in those with the
protein redistributed to theperinucleolar region.Arginines inFUS
are frequently dimethylated (36,37) while this has not been
observed for core paraspeckle proteins p54nrb/NONO, PSF and
PSP1. Therefore it is plausible that the methylation state of FUS
and other essential paraspeckle proteins known to be methylated,
such as hnRNP K (38), regulates relocation of non-methylatable
paraspeckle proteins to the perinucleolar region. In support of
Figure 2. FUS is a component of nucleolar caps completely overlapping with
those formed by paraspeckle proteins in neuroblastoma SH-SY5Y cells. (A)
FUS becomes redistributed to the perinucleolar region upon treatment with
DNA polymerase II inhibitor DRB but does not form nucleolar caps, in contrast
to actinomycin D treatment which induces FUS recruitment to classical crescent
shaped caps. (B and C) N-terminal fragment of FUS (B) and chimeric protein
Sup35–FUS (C) efficiently localize to nucleolar caps upon exposure to actino-
mycin D. (D–F) FUS is not a component of coilin p80 caps (D), but FUS caps
partially colocalize with RNA helicase p68 caps (E) and completely overlap
with caps formed by PSP1 in actinomycin D-treated cells (F). (G) FUS is not es-
sential for redistribution of other paraspeckle proteins to nucleolar caps, since
PSP1-positive caps were observed in actinomycin D-treated cells depleted of
FUS by RNA interference. Actinomycin D or DRB were added to the cells for
1.5 h prior to fixation in all experiments. Scale bars, 10 mm.
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this idea, nucleolar targeting of paraspeckle proteins was no
longer detected in MCF7 cells with significantly decreased FUS
levels achieved by siRNA knockdown (Fig. 4D). Changes in
FUS methylation have been linked to the development of FUSo-
pathies via impaired nuclear transport of methylated ALS-
associated variants and their entrapment in the cytoplasm (39).
In FTLD-FUS, the gene encoding FUS protein is not mutated
but hypomethylation of the protein leads to its redistribution to
the cytoplasm (39) where it forms pathological inclusions (5).
Since a hypomethylated state dramatically affects normal distri-
bution of FUS and other paraspeckle proteins in the nucleus, an
abnormal decrease in methylation levels at early stages of
FTLD-FUSmight disrupt the association of FUS and other para-
speckle proteins with NEAT1 and each other, impairing para-
speckle assemblyandconsequently, cellular protective responses.
Cellular level of FUS regulates paraspeckle assembly
and maintenance
ALS-associated mutations can potentially exert a deleterious
effect via two mechanisms—loss of nuclear function and gain
of toxic function in the cytoplasm. To determine the conse-
quences of FUS deficiency we knocked down FUS expression
by RNA interference. Using a pool of FUS targeting siRNAs
we achieved 75% knockdown at the level of mRNA and
50–70% at the level of protein in COS7, MCF7 or SH-SY5Y
cells at 72 h post-transfection (see Fig. 5B and C for MCF7
cell line). Despite the levels of paraspeckle proteins PSP1 and
p54nrb/NONO remaining unchanged upon FUS knockdown
(Fig. 5C), paraspeckles disappeared from FUS-depleted cells
(Fig. 5A). To assesswhether this effectwas because of decreased
levels ofNEAT1 lncRNAwe performed qRT-PCRwith primers
that simultaneously detect both long (NEAT1_2) and short
(NEAT1_1) isoforms of NEAT1. NEAT1 levels were signifi-
cantly lower in MCF7 cells treated with FUS siRNA compared
with scrambled siRNA control (Fig. 5D). NEAT1 downregula-
tion was previously observed upon knockdown of p54nrb/
NONO and PSF (20), and therefore, it is likely that FUS contri-
butes to maintenance of the steady-state level of NEAT1 tran-
scripts in the same way as these major paraspeckle proteins.
The effect of FUS knockdown on paraspeckles is seemed to be
rescued by overexpression of another paraspeckle protein as
multiple paraspeckle-like and PSP1-positive structures reappear
in COS7 cells with dramatically reduced FUS levels that are
expressing GFP-p54nrb/NONO (Fig. 5F and G). We cannot
completely exclude that these structures represent small
p54nrb/NONO aggregates that also contain PSP1 because of
high affinity heterodimerisation of these two proteins (19,40).
However, these structures were observed in FUS-depleted
cells with a low level of GFP-p54nrb/NONO expression that
does not induce aggregate formation in naı¨ve cells, making our
suggestion that the protein supports formation of physiological
Figure 3. FUS associates with p54nrb/NONO in vivo via RNA and this interaction is regulated by ongoing transcription. (A andB) Immunoprecipitation revealed an
RNase sensitive interaction of p54nrb/NONOwith full-length FUS protein (FUSWT) but not with N-terminal part of FUS (FUSNT) (A) or full-length TDP-43 (B).
Full-length FUS, N-terminal FUS fragment (aminoacids 1–359, NT), p54nrb/NONO or TDP-43 expressing plasmids were transfected into SH-SY5Y cells and 24 h
after transfection immunoprecipitated on anti-GFP antibody coated beads. To test the role of RNA in FUS-p54nrb/NONO interaction the lysate of FUS-GFP WT
transfected cells was treated with RNase A for 30 min at RT prior to incubation with beads. Asterisks mark non-specific bands. (C) Interaction of endogenous
FUS and p54nrb/NONO proteins in COS7 cells. Co-immunoprecipitations of FUS with anti-p54nrb/NONO antibody from cell lysates. A part of very intense
50 kDa immunoglobulin heavy chain band is seen just under the p54nrb/NONO band because the same antibodies were used for immunoprecipitation and
western blotting. (D) FUS remains associated with p54nrb/NONO in actinomycin D but not DRB treated cells. Protein complexes of full-length GFP-tagged FUS
were immunoprecipitated from lysates of SH-SY5Y cells untreated or treated with inhibitors of transcription for 1.5 h.
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Figure 4. Protein methylation regulates distribution of paraspeckle proteins in the nucleus. (A) Paraspeckle proteins p54nrb/NONO, PSP1 and FUS accumulate in the
perinucleolar region in the majority of MCF7 breast cancer cells under basal conditions. (B) Ectopic expression of Flag-tagged MTAP protein in MCF7 cells restores
paraspeckle distribution of endogenous p54nrb/NONOprotein.Cells were fixed and processed for staining 24 h post-transfection.Arrows show p54nrb/NONO-positive
paraspeckles in MTAP-expressing cells. (C) Prolonged (24 h) treatment of neuroblastoma SH-SY5Y cells with MTA, a global inhibitor of protein methyltransferases,
induces redistributionofp54nrb/NONOandFUS intoperinucleolar region ina fractionofcells (arrows). Paraspeckles are still preserved incellswhere such redistribution
did not occur (arrowheads). (D) Perinucleolar localization of PSP1 in MCF7 cells is abolished by siRNA knockdown of FUS expression. Scale bars, 10 mm.
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structures, i.e. paraspecles, very credible. The observed effect
could not be attributed to restoration of NEAT1 levels, since
GFP-p54nrb/NONO expression neither altered NEAT1 levels
in cells with normal FUS expression nor did it rescue the de-
crease in NEAT1 levels in the cells upon FUS knockdown (Sup-
plementary Material, Fig. S3). Therefore, p54nrb/NONO is a
good candidate for substituting the architectural role of FUS in
paraspeckles. Furthermore, we observed that in contrast to
p54nrb/NONO, expression of FUS–GFP does lead to a statistic-
ally significant elevation of NEAT1 levels (Fig. 5E).
Mislocalized FUS traps paraspeckle proteins
in cytoplasmic aggregates in cultured cells
Tomodel toxicgainof functionofALS-associatedFUSmutations,
we expressed FUS variants with impaired NLS in cultured cells.
Despite mislocalization to the cytoplasm, in cells expressing low
levels of a mutant protein all FUS variants tested including trun-
cated FUS lacking 60 C-terminal amino acids (p.G466VfsX14),
were still significantly enriched in paraspeckles further confirming
the high affinity of FUS for these nuclear bodies (Supplementary
Material, Fig. S4A and B). However, in cells accumulating high
levels of mutant FUS protein multiple cytoplasmic aggregates
are formed and in SH-SY5Y cells expressing FUS R522G
p54nrb/NONO was consistently (in 80.3+0.96% of all cells
with aggregates) present in these aggregates (Fig. 6A, arrows).
Similar results were obtained for DNLS or p.G466VfsX14 con-
structs (data not shown). This result was unexpected as p54nrb/
NONO is usually almost entirely restricted to the nucleus in cul-
tured cells. Furthermore, in a small fraction of cells, a significant
amount of p54nrb/NONOwas detected in the aggregates together
with a marked clearance of the protein from the cell nucleus
Figure 5. FUS is important for the integrity of paraspeckles and regulates NEAT1 levels. (A–C) siRNA knockdown of FUS causes loss of paraspeckles in cultured
cells as visualized by immunostaining for core paraspeckle proteins PSP1 and p54nrb/NONO (A andB) without alterations in total levels of these proteins (C). Rep-
resentative images for PSP1andp54nrb/NONOdistribution inCOS7andSH-SY5Ycells andquantification forCOS7cells are shown.Anti-PSP1 stainingwas used to
visualize paraspeckles for counts. Arrows indicate paraspeckles preserved in cells with normal FUS levels. (D andE) FUS protein levels regulate abundance of long
non-coding RNANEAT1.Downregulation of FUS expression by siRNAknockdown significantly decreasesNEAT1 levels (D), while FUS overexpression results in
elevated NEAT1 (E) in MCF7 cells as measured by qPCR with primers specific for both short (NEAT1_1) and long (NEAT1_2) isoforms of NEAT1. Cells were
transfected with either empty pEGFP-C1 vector or GFP-FUS and analysed 24 h post-transfection. Western blotting with anti-FUS antibody shows approximately
equal levels of FUS-GFP and endogenous FUS in total cell culture lysates, considering that efficiency of transfection of MCF7 cells was 25%, transfected cells
expressed approximately 4 times more ectopic than endogenous FUS protein. (F andG) p54nrb/NONO substitutes for loss of FUS function required for paraspeckle
formation. GFP fused p54nrb/NONO expressed in FUS-depleted COS7 cells formed multiple paraspeckle-like structures in dose-dependent manner (F), and these
were positive for PSP1 (G, arrows). In all experiments cellswere transfectedwith either a pool of siRNAspecifically targetingFUSprotein (FUSsiRNA)or scrambled
siRNA (scrmb siRNA) and analysed 72 h post-transfection. ∗P, 0.05 and ∗∗∗P , 0.001 (Mann–Whitney U-test). Error bars represent SEM. Scale bars, 10 mm.
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Figure 6. Cytosolic FUS aggregates sequester paraspeckle proteins. p54nrb/NONO protein is consistently present in aggregates formed by cytoplasmically mislo-
calized FUS bearing anALS-linkedR522G substitution (A, arrows), and in some cells p54nrb/NONO is cleared from the nucleus and accumulates in FUS aggregates
(B, arrowheads). Core paraspeckle proteins PSP1 and PSF are recruited into FUS aggregates in neuroblastoma SH-SY5Y (C and E, arrows) and COS7 (D, arrows)
cells. Cells were analysed 24 h post-transfection. Scale bar, 10 mm.
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(Fig. 6B). PSP1 and another core paraspeckle protein, PSF (poly-
pyrimidine tract-binding protein-associated splicing factor), also
accumulated within the cytosolic FUS aggregates in SH-SY5Y
and COS7 cells (Fig. 6C–E, arrows). In contrast, we failed to
detect p54nrb/NONO in cytoplasmic aggregates formed by
25 kDa C-terminal fragment of TDP-43, and multiple dot-like
nuclearaggregatesof thisproteindidnotoverlapwithparaspeckles
visualized with p54nrb/NONO (Supplementary Material, Fig.
S4C, arrowheads).
P54nrb/NONO accumulates in nuclear and rarely
cytoplasmic inclusions formed by truncated FUS
in a transgenic mouse model
Recently we produced and characterized a transgenic mouse
model of FUSopathy (FUS-TGmouse line) based on aggregation
of C-terminally truncated human FUS (41). In these mice human
FUS protein identical to the NT variant shown in Figure 1C, but
without GFP tag, forms multiple cytoplasmic and nuclear inclu-
sions in selected neuronal populations.Moreover, the recruitment
of endogenous mouse FUS to these inclusions, particularly those
within thenucleus, is observed.Wehypothesized that paraspeckle
proteins might be recruited into FUS inclusions in this transgenic
mouse model through an interaction with endogenous FUS. First
we showed that in mouse nervous tissues p54nrb/NONO is pre-
dominantly nuclear, although in some cells, particularly in large
motor neurons, a large fraction of the protein is also found in the
cytoplasm (Fig. 7A). Co-staining spinal cord sections from symp-
tomatic FUS-TG mice with anti-p54nrb/NONO and N-terminal
specific FUS antibodies revealed a strong p54nrb/NONO immu-
noreactivity and complete overlap with anti-FUS staining for vir-
tually all nuclear FUS aggregates in spinal motor neurons
(Fig. 7E–G). These nuclear inclusions were also evident in con-
ventional immunohistochemistry using detection of the signal
with 3,3′-diaminobenzidine as a substrate (Fig. 7B). With the
higher sensitivity provided by this method compared with im-
munofluorescence, rare p54nrb/NONO-positive cytoplasmic
inclusions were also detected (Fig. 7C and D). PSF was also
detected in a fraction of nuclear but not cytoplasmic FUS inclu-
sions,which is consistentwith its predominantly nuclear localiza-
tion in neurons (Supplementary Material, Fig. S5B and C). In
contrast, PSP1 was found neither in nuclear nor in cytoplasmic
FUS aggregates, although like p54nrb/NONO it is also abundant
inneuronal cytoplasm(SupplementaryMaterial, Fig. S5A). Since
aggregationof truncatedFUSoccursextremelyrapidly(41),prob-
ably after reaching a certain concentration threshold, p54nrb/
NONO and PSF are more efficiently recruited into aggregates in
the nucleus where they predominantly reside, while their lower
levels in the cytoplasmallow formation of cytoplasmic inclusions
only in a fraction of neurons. Potentially, paraspeckles formed in
motorneuronsofFUS-TGmice inresponse todamagingeffectsof
accumulating exogenous protein might become seeding centres
for aggregation of truncated FUS, which sequester endogenous
FUS-p54nrb/NONO-PSF complexes. These aggregation ‘cores’
may subsequently grow and fuse to each other to give rise to
nuclear inclusions.The fact that unlike twoother core paraspeckle
proteins,PSP1 isnot detected infinal productsofFUSaggregation
in neurons of transgenic mice indicates a certain selectivity of
paraspeckle protein co-aggregation and not mere entrapment of
entire paraspeckles.
P54nrb/NONO-positive inclusions are abundant in
spinal motor neurons of ALS-FUS patients but not healthy
controls or other ALS cases
The observed redistribution of p54nrb/NONO protein in cell
culture and in a transgenic mouse model suggested that this
protein could be sequestered into pathological aggregates in
human FUSopathies.We therefore used immunohistochemistry
to evaluate thedistributionof p54nrb/NONOin the spinal cordof
ALS-FUS patients compared with neurologically healthy con-
trols, a case of multiple sclerosis (MS) and sporadic ALS
(sALS) cases. p54nrb/NONO was nuclear in the majority of
small neurons and glial cells but strikingly, displayed prominent
cytoplasmic staining in many motor neurons from non-ALS
individuals (Fig. 8A), and in some of these neurons was com-
pletely excluded from the nucleus (Fig. 8A, MS case). Multiple
p54nrb/NONO immunoreactive nuclear and cytoplasmic inclu-
sions of various sizes were noted in survivingmotor neurons but
not glial cells in two studied ALS-FUS cases (Fig. 8B). Such
structureswere not detected in anyof three control non-ALSsub-
jects (Fig. 8A), nor in three sALS cases including one with con-
firmed presence ofTDP-43 inclusions (Fig. 8C, sALS-TDP), nor
in an ALS-SOD1 case (Fig. 8C, ALS-SOD1).
DISCUSSION
Paraspeckles are nuclear structureswith poorly understood func-
tions, although their importance for selective nuclear retentionof
hyperedited transcripts, selective storage of certain RNAs and
their rapid release under stress conditions have been demon-
strated (22,23). Paraspeckles are present in the nucleus of
almost all cultured cells (42), suggesting that in vitro conditions
favour their assembly and function. However, they are absent in
embryonic stem cells (43) and their presence in mammalian
tissues is subpopulation-specific. Generally, these structures
are abundant in tissues with a high level of expression of the
long non-coding RNA NEAT1, for example, in cells of surface
gastric epithelium (44). Ablation of NEAT1 synthesis in mice
leading to the loss of paraspeckles does not result in any detect-
able abnormalities in animal development (44),which is surpris-
ing because, perceivably, preventing synthesis of defective
proteins from hyperedited transcripts is important for cellular
homeostasis. It is feasible thatNEAT1synthesis andparaspeckle
assembly are constitutive in some types of cells but in other types
of cells occur transiently in response to specific stimuli, such as
certain types of stress (45), and that developmental mechanisms
able to compensate for the loss of paraspeckle function become
activated in the knockdownmodel. Although under normal con-
ditions the level ofNEAT1 is low in the nervous tissue andprom-
inent paraspeckles are absent from neurons (44), enhanced
NEAT1 expression and nucleation of paraspeckles have been re-
cently observed in motor neurons at early stages of ALS devel-
opment (16). One interpretation of this finding is that
formation of paraspeckles represents an early protective re-
sponse of these neurons to some deleterious insults. If so,
events/factors impairing this pathway would weaken or even
remove this protective barrier. Several lines of evidence led us
to suggest that such impairment may contribute to the develop-
ment of neuronal dysfunction in human FUSopathies.
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We demonstrated that FUS is not only an integral component
of paraspeckles, as has been shown previously (15), but also sig-
nificantly contributes to their stability byboth regulatingNEAT1
steady-state levels and maintaining the structure of this nuclear
body. Therefore, nuclear deficiency of FUS typical of FUSopa-
thiesmay impede paraspeckle formation needed for an adequate
response to stress. Furthermore, our data obtained in cultured
cells, transgenic mice and human post-mortem tissue indicate
that in addition to the loss of its own nuclear function, FUS ag-
gregationmight cause sequestration of paraspeckle components
into pathological inclusions. One of them, p54nrb/NONO, has
been implicated in multiple and diverse cellular functions,
including splicing regulation (46,47), DNA unwinding (48), tar-
geting DNA binding proteins to their binding sites (14), tran-
scription termination (49), DNA repair (50) and circadian
rhythm maintenance (51). Therefore, its entrapment in inclu-
sions and subsequent withdrawal from cellular metabolism
would be expected to negatively affect these pathways and
may contribute the progression of pathology independently of
a direct effect on paraspeckle formation.
Taken together results of our studies support a model of dis-
ruptedprotective functionof paraspeckles triggeredbyFUSmis-
localization and aggregation (Fig. 9). According to this model,
neuronal cells respond to deleterious external and internal
Figure 7. p54nrb/NONO is sequestered into cytoplasmic and nuclear inclusions formed by truncated FUS in a transgenic mousemodel of FUSopathy. (A) Immuno-
histochemical stainingwith antibody against p54nrb/NONOshows that the protein accumulates in the cytoplasmof large spinalmotor neurons but in the cytoplasmof
small neurons andglial cells of non-transgenicmice. (B–G) p54nrb/NONOis detected in virtually all nuclear FUSaggregates by double immunofluorescence (arrow-
heads in highermagnification image shown inG).Occasionally p54nrb/NONOis also detectedby immunohistochemistry in cytoplasmic inclusions (C andD, arrows)
formed by truncated FUS protein in spinal motor neurons of symptomatic FUS-TG mice. Both truncated and endogenous FUS were visualized by an antibody rec-
ognizing an N-terminal FUS epitope (N-term FUS) present in both proteins. Scale bars, A–D: 15 mm; E and F: 35 mm; G: 10 mm.
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factors by activation of a protective mechanism leading to upre-
gulation of NEAT1 levels and formation of paraspeckles.
However, in conditions of nuclear FUS deficiency occurring in
FUSopathies, the high level of NEAT1 required for their assem-
bly cannot be achieved or maintained. Moreover, FUS abnor-
mally deposited in the cytoplasm sequesters other paraspeckle
proteins decreasing their nuclear pool. As a result of the defi-
ciency of key structural elements at the early stages of FUSopa-
thy development, the assembly of paraspeckles is compromised
and the paraspeckle-based response is impaired, which contri-
butes to progression of neuronal pathology.
It is becoming increasingly recognized that paraspeckle func-
tion becomes important under conditions of stress (44,45), and
impairment of the paraspeckle response may lead to dramatic
consequences, especially in long-living cells such as neurons.
We have demonstrated that deregulation of FUS protein, a struc-
tural component of paraspeckles, caused by mutation or post-
translational modifications associated with certain types of
neurodegeneration, can perturb this pathway. So far, FUS is
the onlyparaspeckle protein directly linked to neurological path-
ology; in the present study we demonstrated the involvement of
other components of these nuclear bodies in FUS-mediated neu-
rodegeneration. Interestingly, the presence of PSF in the insol-
uble proteome in FTLD brains has been recently reported (52).
These observations suggest the need for further studies of the
role of paraspeckle components in the pathogenesis of FUSopa-
thies, and scrutiny of their ability to cause neuronal pathology in-
dependently of FUS.
MATERIALS ANDMETHODS
Expression plasmids, transfection and treatments
DNA fragments encoding full-length FUS, TDP-43, p54nrb/
NONOandMTAP, truncatedFUSvariants, FUSvariants carrying
mutations, and prion domain of Sup35 protein were produced by
RT-PCR amplification with SuperScript III and AccuPrime poly-
merases (Invitrogen) from human (SH-SY5Y cells) total RNA
using corresponding primers, cloned into pCR-BluntII-TOPO
vector (Invitrogen). After sequence validation DNA fragments
subcloned into the pEGFP-C1 vector (Clontech) downstream of
and in-frame with GFP or in pFlag-CMV4 vector (Sigma).
Figure 8. p54nrb/NONO is a constituent of cytoplasmic and nuclear inclusions in human familial ALS-FUS. (A) p54nrb/NONO is confined to the nucleus in the
majority of glial cells and small neurons in the spinal cord of non-ALS individuals (control#1). However, in spinal motor neurons p54nrb/NONO is present at con-
siderable levels in the cytoplasm. Representative images of spinal motor neurons from two healthy individuals and one MS case stained with anti-p54nrb/NONO
antibody are shown. (B) Multiple nuclear and cytoplasmic p54nrb/NONO-positive inclusions are detected in two familial ALS cases with FUS mutations
(ALS-FUS). (C) p54nrb/NONO is diffusely distributed in the nucleus and cytoplasmof sporadicALS (sALS) cases, including a casewith confirmedTDP-43 inclusions
(sALS-TDP), as well as in a case of familial ALS with SOD1 mutation (ALS-SOD1). Scale bars, 30 mm.
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SH-SY5Y human neuroblastoma cells, COS7 and MCF7 cells
were maintained in Dulbecco’s modified Eagle’s medium
(Invitrogen), supplemented with 10% fetal bovine serum. For im-
munofluorescencecellsweregrownonpoly-L-lysinecoatedcover-
slips. Cells were transfectedwith expression plasmids and/or FUS
siRNA using Lipofectamine2000 (Invitrogen) according to the
manufacturer’’s instructions. siRNA-mediated knockdown of en-
dogenous FUS was achieved using FUS-specific SiGENOME
SMART pool M-009497-02 (target sequences: 5′-ccua
cggacagcagaguua-3′, 5′-gauuauacccaacaagcaa-3′, 5′-gaucaauccu
ccaugagua-3′, 5′-cgggacagcccaugauuaa-3′) (Thermo Scientific).
As a control for off-target effects, non-specific scrambled siRNA
(target sequence: 5′-ggacuaauaguugugcuccaauuua-3′) (Invitro-
gen) was used. To block transcription cells were treated with
5 mg/ml actinomycin D (Calbiochem) or 25 mg/ml DRB(Sigma)
for 2 h. To decrease levels of protein methylation 5′-deoxy-
5′-methylthioadenosine (MTA) was applied to SH-SY5Y cells
in fullmediumat a final concentration of 750 mMfor 24 h. For nu-
cleolus staining living cells were exposed to 10 mg/ml of ethidium
bromide for 2 hs prior to fixation.
Immunofluorescence on coverslips
Cells were fixed with 4% paraformaldehyde on ice for 15 min,
followed by washes with PBS and 5 min permeabilization in
cold methanol. After three washes with PBS and blocking in
5%goat serum/PBS/0.1%TritonX-100 for 1 h at room tempera-
turecoverslipswere incubatedwithprimaryantibodiesdiluted in
blocking solution for 1 h at room temperature or at 48C over-
night. Alexa Fluor-conjugated anti-mouse or anti-rabbit immu-
noglobulins (Molecular Probes, Invitrogen) were used as
secondary antibodies (1:1000 in PBS/0.1% Triton X-100) and
cell nuclei were visualized with DAPI. Fluorescent images
were taken using BX61 microscope (Olympus) and processed
using CellF software (Olympus).
Human tissue samples
Human spinal cord paraffin sections from clinically and histo-
pathologically characterized disease and control cases were
obtained from the MRC London Neurodegenerative Diseases
Brain Bank (Institute of Psychiatry, King’s College, London).
Consent was obtained from all subjects for autopsy, histopatho-
logical assessment and research in accordancewith local and na-
tional Ethics Committee approved donation.
Immunohistochemistry
Mouse tissues were fixed, embedded in paraffin wax and 8 mm
thick sections mounted on poly-L-lysine coated slides as
described previously (53). Human spinal cord samples embed-
ded in paraffin were cut 7 mm thick. Immunostaining was per-
formed using Elite plus kits (Vector laboratories) and
3,3′-diaminobenzidine (DAB, Sigma) as a substrate.Microwave
antigen retrieval in sodium citrate buffer was performed prior to
all stainings. For double immunofluorescence, secondary Alexa
Fluor-conjugated antibodies (1:1000, Molecular Probes, Invi-
trogen) were used and nuclei were stained with DAPI. The
same microscope, camera and software were used as described
above for epifluorescence and fluorescence imaging of stained
tissue.
Figure 9. A hypothetical scheme describing how mislocalization of FUS protein typical for human FUSopathies may disrupt early response of neurons to stressful
conditions because of compromised paraspeckle formation.
Human Molecular Genetics, 2014, Vol. 23, No. 9 2309
 at A
cquisitions on O
ctober 7, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
Primary antibodies
Commercially available primary antibodies against the following
antigens were used: FUS (rabbit polyclonal, #ab84078, Abcam;
mouse monoclonal, #sc-47711, Santa Cruz; mouse monoclonal,
#sc-135911, Santa Cruz; mousemonoclonal, #611385, BDBios-
ciences); p54nrb/NONO (rabbit polyclonal C-terminal, Sigma);
PSP1 (rabbit polyclonal N-terminal, Sigma); PSF (SFPQ, AB2,
Sigma); Flag peptide (M2, Sigma); SMN (mouse monoclonal,
#610646, BD Biosciences); p80 coilin (mouse monoclonal,
#612074, BD Biosciences); Smith antigen (Y12, rabbit poly-
clonal, #ab3138, Abcam); TDP-43 (rabbit polyclonal,
#SAB3500236,Sigma);PML(chicken, a kind gift fromProfessor
Ronald Hay, Dundee); GFP (Living Coloursw rabbit polyclonal,
#632593, Clontech); p68 (rabbit monoclonal, clone D15E10,
Cell Signaling); beta-actin (mouse monoclonal, AC15, Sigma).
Primary antibodies were used at 1:1000 dilution for all applica-
tions. For staining of human samples antibodies against p54nrb/
NONO were used in 1:500 dilution.
Immunoprecipitation
At 24 h post-transfection, cells were washed in PBS and lysed in
ice cold IP buffer (PBS/1% Triton X-100) and left on ice with
periodic vortexing for 20 min. Unbroken cells and cell debris
were pelleted at 13 000 rpm for 20 min in a sold centrifuge
and supernatant collected for IP. Input sample was taken at this
point. Cell lysates were preincubated with anti-GFP antibody
(Protein Synthesis, clone 3A9) for 30 min followed by incuba-
tion with ProteinA/G sepharose beads (GE Healthcare) or with
GFP-Trapw agarose beads (ChromoTek) omitting the antibody
step, for 2 h at 48C. Beads were washed twice in ice cold IP
buffer, and bound immunocomplexes were eluted from beads
by boiling for 10 min at 1008C in SDS–PAGE loading buffer.
In the case of ProteinA/G sepharose beads, control samples
were prepared by omitting the antibody step. To remove
beads, samples were centrifuged at 2000g for 2 min. Samples
were then analysed by western blotting. For input 10% of final
IP sample was loaded.
RT-PCR and qPCR
Total RNA was isolated using RNeasy mini kit (Quiagen) and
possible DNA contamination removed using RNase free
DNase kit (Qiagen). First-strand cDNA synthesis was carried
out on 500 mg RNA using SuperScript III reverse transcriptase
(Invitrogen) and randomhexamers (Promega) according toman-
ufacturer’s instructions. Quantitative real-time PCR was run in
triplicate on an ABI StepOneTM real-time PCR instrument and
data were analysed using StepOneTM Software v2.0 (Applied
Biosystems) according to (54). cDNA amount for each gene
was normalized to that of GAPDH. Primer sequences used
were as follows: FUS—forward: 5′-tctttgtgcaaggcctgggt-3′;
reverse: 5′-taatcatgggctgtcccgtt-3′; NEAT1—forward: 5′-cttcc
tccctttaacttatccattcac-3′; reverse: 5′-ctcttcctccaccattaccaacaa
tac-3′; GAPDH—forward: 5′-tcgccagccgagcca-3′; reverse:
5′-gagttaaaagcagccctggtg-3′.
Western blotting
For SDS–PAGE loading buffer was used to lyse cells on dishes,
followedbydenaturation at 1008Cfor 5 min.After SDS–PAGE,
proteins were transferred to PVDF membrane by semi-dry blot-
ting followed by blocking, incubation with primary and horse
radish peroxidase-conjugated secondary (GE Healthcare) anti-
bodies and ECL detection as described previously (55,56).
Equal loading was confirmed by re-probing membranes with
antibodies against beta-actin.
Statistics
Statistical analysis was performed with Mann–Whitney U-test
using IBM SPSS Statistics software (IBM).
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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